Upregulation of TGF-β1 plays a crucial role in the activation of hepatic stellate cells (HSCs) and the generation of the extracellular matrix after acute and chronic liver damage, which accelerates the development of MASLD [39]. The gene discussed is TGFB1; the disease is metabolic dysfunction-associated steatotic liver disease.